Neurodegenerative diseases Flashcards

1
Q

Therapy of Parkinsons disease

A

Increase dopamine levels:
Levadopa, MAO-B inh, Dopamine AG, COMT inhbitiors, amantadine
Decrease Ach:
Centrally acting anticholinergic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Levodopa

A

Precursor of dopamine, can cross the BBB. Given in combination with Carbidopa or Benserazide (DCC inhibitors).
I: Parkinsons disease
SE: acute peripheral: nausea, diarrhea (area pastrami has no BBB), arrhythmias, hypotension. Acute central: depression, psychosis, anxiety. Decreased BP (D Rs stim in kidney), tachycardia (D stim beta1 Rs), Dyskinesia, End of dose phenomena, on-off phenomena
Should be started as late as possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

End of dose phenomena. which drug and why

A

Levodopa.
After taking the drug - patient can mote. As the effect of levodopa suddenly wears off/stops, akinesia will develop.
if patient moves more - effect is shorter.
Is related to serum level of dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

On-Off phenomena. Which drug and why

A

Levodopa
ON: levodopa induced dyskinesia (choreoattatoid dyskinesia)
OFF: akinesia
Alteration btwn on and off phase. Not related to serum levels of dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MAO-B inhibitors

A

Selegiline (Sledgehammer)
Rasagiline
Safinamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Selegiline

A

irreversible MAO-B inhibitor (CNS)
Used for early treatment of PD. Is also an antioxidant -neuroprotective.
I: PD, alzheimers, depression.
SE: no cheese reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Resegiline, Safinamide

A

irreversible MAO-B inhibitors. act in the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dopamine D2 AGs

A

Ergot derivatives: Bromocryptine, Cabergoline
Non-ergot derivatives: Pramipexole, Ropinirole, Rotigotine, Apomorphine
all act in the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bromocryptine, Cabergoline

A

Are central D2 R AG

Not used anymore - can cause subendocardial fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pramipexole, Ropinirole

A

Ropinorole (rope in a roll), Pramipexole (Big Pecs)
Are both central D2 AG, and are both taken orally. PD treatment.
SE:Nausea, vomiting, dyspepsia, orthostatic hypotension, arrhythmias, dyskinesias, confusion, delusions, impulse control disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rotigotine

A

D2 R AG. Given as a patch. PD treatment.
SE: nausea, vomit, constipation, dyspepsia, orthostatic hypotension, arrhythmias, dyskinesias, impulse controll disorders. etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Apomorphine

A

D2 R AG - given as injection. PD treatment.
SE: Nausea, vomit, constipation, dyspepsia, orthost. hypotension, arrhythmias, dyskinesias, confusion, hallucinations, impulse controll disorders etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

COMT inhibitors

A

(inTerCOM) - The capone family
Entacapone (Entering al capone gangster)
Opicapone
Tolcapone (Tall al capone ganster)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Entacapone, opicapone

A

Are inhibitors of peripheral COMT - prevent formation of levodopa to 3-methyldopa in periphery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tolcapone

A

Central and peripheral COMT inhibitor. prevents formation of levodopa to 3-methyldopa (periphery), and 3-methylTyramine (in CNS).
Always given in combo with levodopa, increases its bioavailability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Amantedine

A

(Manatee). An antiviral.
Mech of action: NDMA ATG, inhibit D reuptake and stim. D release and synthesis. Adenosine A2A receptor ATG, Anticholinergic effect.
I: Akinetic crisis (patient has lost all movement capacity) - stop levodopa and give amantedine for 1 week.
SE: mental, seizure at high doses, not effective when given orally.

17
Q

centrally Acting cholinergic drugs (Ach M-receptor ATG)

A

Procyclidine, Benztropine (Benz car)
biperiden, trihexyphenidyl (3 hexagons on car), Orphenadrine, Dexethimide, metixene.
Have good CNS penetration.

18
Q

Procyclidine, benztropine, trihexyphenidyl

A

Centrally acting anticholinergic drug.
I: drug induced parkinsonism (from antipsychotics), tremor dominated PD only, treatment of early EPS and perioral EPS (a late eps).
SE: atropine like: dry mouth, consitpation, mydriasis, blurred vision. Cognitive dysfunction (dementia like)

19
Q

Treatment of Parkinsons disease, from start to end

A

1) Selegiline - at diagnosis
2) Amantadine + selegiline
3) Dopamine AG + amantadine + selegiline
4) Levodopa + carbidopa + COMT inhibitors and dopamine AG+amantadine+selegiline

20
Q

Treatment of drug induced psychosis in PD

A

Clozapine (a 2nd generation antipsychotic drug)

21
Q

Treatment of Alzheimers disease

A

Increase of Ach.
AchEase inhibitors:
Tacrin, Rivastigmine, Donezepil, Galantamine
NMDA ATG: Memantine
NSAIDs: ibuprofen, indometacine (inhibits gamma-secretase)
other: amyloid vaccination, amyloid ABs, antioxidants

22
Q

Cause of Alzheimer disease

A

amyloid theory and Tau hypothesis - result is loss of cholinergic neurons.

23
Q

Tacrin

A

AchEase inhibitor

SE: hepatotoxic, nausea, vomiting, diarrhea, short duration of action

24
Q

Rivastigmine

A

AchEase inhibitor. longer duration of action

25
Q

Galantamine

A

AchEase inhibitor + weak nicotine R AG

26
Q

Donezepil

A

AchEase inhibtor

No hepatotoxicity